Johnson & Johnson (NYSE:JNJ) shares traded -0.07% lower at $152.39 on Wall Street last session.
JNJ stock price is now -3.73% away from the 50-day moving average and -4.36% away from the 200-day moving average. The market capitalization of the company currently stands at $367.07B.
With the price target reduced from $170 to $163, Wells Fargo Downgraded its rating from Overweight to Equal Weight for Johnson & Johnson (NYSE: JNJ). On December 01, 2023, UBS Upgraded its previous ‘Neutral’ rating to ‘Buy’ on the stock increasing its target price from $167 to quote $180, while ‘RBC Capital Mkts’ rates the stock as ‘Outperform’
In other news, Broadhurst Vanessa, EVP, Global Corp Affairs sold 8,891 shares of the company’s stock on Mar 13 ’24. The stock was sold for $1,441,765 at an average price of $162.16. Upon completion of the transaction, the EVP, Global Corp Affairs now directly owns 15,043 shares in the company, valued at $2.29 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 16 ’24, 10% Owner JOHNSON & JOHNSON sold 3,725 shares of the business’s stock. A total of $96,142 was realized by selling the stock at an average price of $25.81. This leaves the insider owning 4,099,575 shares of the company worth $624.73 million. A total of 0.16% of the company’s stock is owned by insiders.
During the past 12 months, Johnson & Johnson has had a low of $144.95 and a high of $175.97. As of last week, the company has a debt-to-equity ratio of 0.44, a current ratio of 1.16, and a quick ratio of 0.91. According to the stock market information, the enterprise value for the company is $373.63B, which is based on a 27.32 price-to-earnings ratio, a 5.81 price-to-earnings-growth ratio, and a beta of 0.53. The fifty day moving average price for JNJ is $158.15 and a two-hundred day moving average price translates $159.27 for the stock.
The latest earnings results from Johnson & Johnson (NYSE: JNJ) was released for Dec, 2023. According to the Drug Manufacturers – General Company, earnings per share came in at $2.29, beating analysts’ expectations of $2.28 by 0.01. This compares to $0.53 EPS in the same period last year. The net profit margin was 15.23% and return on equity was 18.57% for JNJ. The company reported revenue of $13.53 billion for the quarter, compared to $12.55 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 7.84 percent. For the current quarter, analysts expect JNJ to generate $21.41B in revenue.
